[go: up one dir, main page]

Wada et al., 1998 - Google Patents

Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration

Wada et al., 1998

View PDF
Document ID
9573129158340915903
Author
Wada Y
Nakashima O
Kutami R
Yamamoto O
Kojiro M
Publication year
Publication venue
Hepatology

External Links

Snippet

We examined the clinicopathologic features of 11 surgically resected hepatocellular carcinomas (HCCs) less than 3 cm in diameter with marked inflammatory cell infiltration (LHCCs). In comparison with the other 152 HCCs without such an infiltration (controls), there …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay for cancer involving oncogenic proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate

Similar Documents

Publication Publication Date Title
Wada et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration
Lipponen et al. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer
Lam et al. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall
Mansi et al. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.
Paal et al. A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature
Tiffet et al. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus
Mattia et al. Breast lymphoma: a B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue
Chott et al. Peripheral T-cell lymphomas of the intestine
Wright Management of thymomas
Ballesteros et al. CD5+ low-grade marginal zone B-cell lymphomas with localized presentation
Thong-Ngam et al. Diagnostic role of serum interleukin-18 in gastric cancer patients
Wang et al. Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature
Deyrup et al. Leiomyosarcoma of the kidney: a clinicopathologic study
Rozeik et al. Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
Aguilera et al. T-cell lymphoma presenting in the breast: a histologic, immunophenotypic and molecular genetic study of four cases
Mori et al. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma
Huang et al. Transforming growth factor β is a poor prognostic factor and inhibits the favorable prognostic value of CD8+ CTL in human hepatocellular carcinoma
Lasota et al. Cytokeratin-positive large-cell lymphomas of B-cell lineage: A study of five phenotypically unusual cases verified by polymerase chain reaction
El‐Bassiouni et al. Immunohistochemical expression of CD95 (Fas), c‐myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma
Ji et al. Intraductal papillary neoplasms of bile duct. A distinct entity like its counterpart in pancreas
Banks et al. Anaplastic large cell (Ki-1) lymphoma with histiocytic phenotype simulating carcinoma
Darwish et al. Prognostic significance of CD24 expression in gastric carcinoma
Paulli et al. Primary gastric CD30 (Ki‐1)‐positive large cell non‐Hodgkin's lymphomas. A clinicopathologic analysis of six cases
Lind et al. Carcinoembryonic antigen staining in choriocarcinoma
Yashiro et al. CD54 expression is predictive for lymphatic spread in human gastric carcinoma